AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Nitric Oxide Donor Reverses Drug Resistance In Breast Cancer and Melanoma Cells.(report from Cellegy Pharmaceuticals Inc.)

Women's Health Weekly

| January 17, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 JAN 17 - (NewsRx.com & NewsRx.net) -- Cellegy Pharmaceuticals, Inc., announced promising results of an in vitro study using nitric oxide (NO) donors to decrease resistance of cancer cells to chemotherapeutic drugs.

The paper was authored by Dr. Charles Graham and his coinvestigators at Queen's University, Kingston, Ontario, Canada. Graham is a consultant to Cellegy Pharmaceuticals and is one of the inventors of patent applications filed by Vaxis Therapeutics Corporation on the use of nitric oxide donors for the prevention and treatment of cancer. These patent applications are now part of Cellegy's intellectual property portfolio through the company's recent acquisition of Vaxis.

In the paper, Graham reported that cancer cells (human breast cancer cells, MDA-MB-231, and mouse melanoma cells, B16F10) made resistant to chemotherapeutic agents, 5-fluorouracil and doxorubicin by causing them to become hypoxic following ...

Related articles from newspapers, magazines, journals, and more
Cellegy Pharmaceuticals Licenses Rights to Nitric Oxide Donor Patent in China...
Press release article from: PR Newswire November 22, 2005 700+ words
...FirstCall/ -- Cellegy Pharmaceuticals, Inc. announced...manufacture and market a nitric oxide donor product for...develop its own nitric oxide donor products...About Cellegy Cellegy Pharmaceuticals is a specialty...603, both of Cellegy Pharmaceuticals, ...
Cellegy Pharmaceuticals licenses rights to nitric oxide donor patent in China...
News wire article from: Chemical Business Newsbase November 22, 2005 700+ words
...NewsBase - Press Release) Cellegy Pharmaceuticals Inc (Cellegy) has licensed...manufacture and market a nitric oxide donor product for the treatment...Zealand, Singapore and the UK. Cellegy Pharmaceuticals is a speciality biopharmaceutical...
Cellegy Pharmaceuticals Acquires Additional Patent Rights to Nitric Oxide Donor...
Press release article from: PR Newswire June 5, 2003 700+ words
Cellegy Pharmaceuticals, Inc. announced...fast-acting nitric oxide (NO) donors...United States." Cellegy Pharmaceuticals is a specialty...CEO, both of Cellegy Pharmaceuticals, +1-650...
Cellegy Pharmaceuticals acquires additional patent rights to nitric oxide donor...
News wire article from: Asia Africa Intelligence Wire June 5, 2003 700+ words
...NewsBase - Press Release) Cellegy Pharmaceuticals Inc (Cellegy) has licensed...combinations of fast-acting nitric oxide (NO) donors, such as...chronic anal fissures. Cellegy Pharmaceuticals is a speciality biopharmaceutical...
Cellegy Pharmaceuticals Consultant Receives U.S. Army Grant for Prostate Cancer...
Press release article from: PR Newswire February 24, 2003 700+ words
Cellegy Pharmaceuticals, Inc. announced...the production of nitric oxide (NO) in the tumor...breast cancer." Cellegy Pharmaceuticals is a specialty biopharmaceutical...disorders. The use of nitric oxide donors for reducing...
Cellegy Pharmaceuticals Second Quarter 2004 Conference Call Alert.
Press release article from: PR Newswire August 5, 2004 700+ words
...number 9269635. About Cellegy Cellegy Pharmaceuticals is a specialty biopharmaceutical...nitroglycerin ointment) a nitric oxide donor for the treatment of...President & CEO, both of Cellegy Pharmaceuticals, +1-650-616-2200...
Cellegy Pharmaceuticals Second Quarter 2003 Conference Call & Business Update.
Press release article from: PR Newswire August 11, 2003 700+ words
...number 2143023. About Cellegy Pharmaceuticals Inc. Cellegy Pharmaceuticals is a specialty biopharmaceutical...sexual dysfunction, and nitric oxide donor technologies...691-7100, for Cellegy Pharmaceuticals Inc.; or K.Michael...
Cellegy Pharmaceuticals Announces Regulatory Affairs Staff Changes; Engages...
Press release article from: PR Newswire August 14, 2003 700+ words
Cellegy Pharmaceuticals, Inc. announced...experience. Cellegy Pharmaceuticals is a specialty...the use of nitric oxide donors for...hypogonadism. Other nitric oxide donor products...both of Cellegy Pharmaceuticals, Inc...
Cellegy Pharmaceuticals Reports First Quarter Financial Results.
Press release article from: PR Newswire May 6, 2004 700+ words
Cellegy Pharmaceuticals, Inc. reported today that...issued under the SSO. About Cellegy Pharmaceuticals Cellegy Pharmaceuticals is a specialty biopharmaceutical...dysfunction, and the use of nitric oxide donors for the treatment...
Cellegy Pharmaceuticals at Harris Nesbitt Gerard Healthcare Conference 2003 -...
News wire article from: The America's Intelligence Wire December 11, 2003 700+ words
...Officer of Cellegy Pharmaceuticals. Cellegy...formulations and nitric oxide donor technologies...PRESIDENT, CEO, CELLEGY PHARMACEUTICALS: I deeply...graphic. So, Cellegy Pharmaceuticals is a company...effectively with nitric oxide donors...
For more facts and information, see all results

Source: HighBeam Research, Nitric Oxide Donor Reverses Drug Resistance In Breast Cancer and...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA